PRICE T ROWE ASSOCIATES INC /MD/ - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 238 filers reported holding IMMUNOGEN INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$61,996
+41.5%
3,906,370
+68.2%
0.01%
+50.0%
Q2 2023$43,822
+9905.0%
2,322,261
+1938.4%
0.01%
Q1 2023$438
-15.9%
113,928
+8.5%
0.00%
Q4 2022$521
-99.9%
105,050
+4.2%
0.00%
Q3 2022$482,000
+121.1%
100,823
+108.3%
0.00%
Q2 2022$218,000
-2.7%
48,413
+3.0%
0.00%
Q1 2022$224,000
-16.4%
46,993
+30.3%
0.00%
Q4 2021$268,000
-46.1%
36,073
-58.9%
0.00%
Q3 2021$497,000
-13.3%
87,688
+0.9%
0.00%
Q2 2021$573,000
-15.6%
86,902
+3.7%
0.00%
Q1 2021$679,000
+41.2%
83,786
+12.3%
0.00%
Q4 2020$481,000
+968.9%
74,592
+502.8%
0.00%
Q3 2020$45,000
-21.1%
12,3750.0%0.00%
Q2 2020$57,000
+46.2%
12,375
+8.8%
0.00%
Q1 2020$39,000
-98.4%
11,373
-98.9%
0.00%
Q3 2019$2,445,000
+28.7%
1,010,498
+15.4%
0.00%
Q2 2019$1,900,000
-71.3%
875,490
-64.1%
0.00%
-100.0%
Q1 2019$6,614,000
-41.0%
2,440,764
+4.4%
0.00%
-50.0%
Q4 2018$11,219,000
-47.8%
2,337,293
+2.9%
0.00%
-33.3%
Q3 2018$21,504,000
-23.8%
2,270,747
-21.7%
0.00%
-25.0%
Q2 2018$28,208,000
+21.4%
2,899,111
+31.2%
0.00%0.0%
Q1 2018$23,240,000
+83.5%
2,209,113
+11.8%
0.00%
+100.0%
Q4 2017$12,664,000
+77.0%
1,975,716
+111.3%
0.00%
+100.0%
Q3 2017$7,154,000
+3550.0%
935,136
+3283.8%
0.00%
Q2 2017$196,000
+83.2%
27,636
+0.1%
0.00%
Q1 2017$107,000
+91.1%
27,6000.0%0.00%
Q4 2016$56,000
-71.9%
27,600
-62.8%
0.00%
Q3 2016$199,000
-13.1%
74,2000.0%0.00%
Q2 2016$229,000
-36.7%
74,200
+74.6%
0.00%
Q1 2016$362,000
-37.3%
42,5000.0%0.00%
Q4 2015$577,000
+119.4%
42,500
+55.1%
0.00%
Q3 2015$263,000
-43.6%
27,400
-15.4%
0.00%
Q2 2015$466,000
+60.7%
32,4000.0%0.00%
Q1 2015$290,000
+42.2%
32,400
-3.0%
0.00%
Q4 2014$204,000
-36.2%
33,413
+10.6%
0.00%
Q3 2014$320,000
-10.6%
30,2000.0%0.00%
Q2 2014$358,000
+12.6%
30,200
+41.8%
0.00%
Q1 2014$318,000
-49.0%
21,300
-50.0%
0.00%
Q4 2013$624,000
+71.9%
42,600
+100.0%
0.00%
Q3 2013$363,00021,3000.00%
Other shareholders
IMMUNOGEN INC shareholders Q4 2021
NameSharesValueWeighting ↓
Redmile Group, LLC 10,477,879$37,720,0000.69%
QVT Financial LP 1,375,900$4,953,0000.60%
RA Capital Management 7,040,485$25,346,0000.46%
Birchview Capital, LP 380,000$1,368,0000.46%
XTX MARKETS LLC 18,861$68,0000.33%
Fernwood Investment Management, LLC 154,340$556,0000.26%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$375,0000.14%
Virtus ETF Advisers LLC 70,213$253,0000.13%
KENNEDY CAPITAL MANAGEMENT LLC 1,251,458$4,505,0000.13%
Assenagon Asset Management S.A. 4,987,334$17,954,0000.10%
View complete list of IMMUNOGEN INC shareholders